✦ LIBER ✦

The new designer peptide CD-NP unloads the heart, suppresses renin and is natriuretic in vivo

✍ Scribed by Ondrej Lisy; John C. Burnett

Book ID: 119588709
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 79 KB
Volume: 9
Category: Article
ISSN: 1532-8414
DOI: 10.1016/s1071-9164(03)00454-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiorenal Actions of the Designer Natr

Cardiorenal Actions of the Designer Natriuretic Peptide, CD-NP, in a Severe Heart Failure Model Treated with Furosemide

✍ Elizabeth C. Costello; Guido Boerrigter; Sarah Mangiafico; Alessandro Cataliotti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The design, synthesis and cardiorenal ac

The design, synthesis and cardiorenal actions of a new chimeric natriuretic peptide CD-NP

✍ Lisy, Ondrej; Burnett, John C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The novel dual GC-A and GC-B designer na

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Sarah Mangiafico; Alessandro Catal 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 94 KB

THE EXPRESSION OF BRAIN NATRIURETIC PEPT

THE EXPRESSION OF BRAIN NATRIURETIC PEPTIDE MRNA IS UP-REGULATED IN ISCHEMIC HEART TISSUE IN VIVO AND IN VITRO

✍ Ye, Weiping; Lee, Daniel; Chandrakala, Aluganti N.; Parthasarathy, Sampath; Zwei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Increase in Left Ventricular Pro-Fibroti

Increase in Left Ventricular Pro-Fibrotic Genes with LVAD Therapy and Potential Anti-Fibrotic Therapeutic Properties of the Novel Designer Natriuretic Peptide CD-NP in Cultured Human Cardiac Fibroblasts

✍ Tomoko Ichiki; John A. Shirger; Frank C. Brozovich; Brenda K. Huntley; S. Jeson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Cenderitide (CD-NP), a novel peptide des

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

✍ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.